FRIDAY, Sept. 27, 2024 (HealthDay News) -- The first new type of medication in decades to help fight against schizophrenia ...

Alembic Pharmaceuticals receives FDA approval for Paliperidone Tablets, trading at ₹1,179.95 on NSE, expanding its global ...

Establishment Labs Holdings shares jumped nearly 30% in premarket trading Friday after the medical-technology company won Food and Drug Administration approval for its Motiva breast implants.

Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This drug takes the first new approach to schizophrenia treatment in decades,” ...

The gene therapy comes seven years after another research group at the university helped come up with the first FDA approved gene therapy for an inherited disease.

Drinking too much coffee has a reputation of being harmful, but a new study says having three cups a day can lower the risk of developing more than one cardiometabolic disease.

Alembic Pharmaceuticals receives USFDA approval for its generic version of Paliperidone extended-release tablets, indicated ...

Paliperidone extended-release tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg have an estimated market size of $48 million for 12 ...

Bristol-Myers Squibb won Food and Drug Administration approval late Thursday for its novel schizophrenia drug, Cobenfy. BMY ...

The federal program has been reopened on the heels of a summer COVID-19 virus wave and heading into the fall and winter ...

A popular podcast mentioned it earlier this year, sources say, but the FDA suggests users should be aware of unlisted ingredients.

Mumbai: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug ...